Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin

By Yi Nam-Joon   Choi Jong   Suh Kyung-Suk   Cho Jai   Baik Minjung   Hong Geun   Lee Kwang-Woong   Kim Won   Kim Yoon   Yoon Jung-Hwan   Lee Hyo-Suk   Kim Dong  

Journal of Gastroenterology, Vol. 48, Iss. 12, 2013-12 ,pp. : 1401-1410

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B

By Chung Goh  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2509-2509

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B

By Karino Yoshiyasu  

Hepatology International, Vol. 4, Iss. 4, 2010-12 ,pp. : 789-790

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy

By Gelderblom Huub   Zaaijer Hans   Dijkgraaf Marcel   Van Der Meer Jan   Weegink Christine   Jansen Peter   Beld Marcel   Reesink Henk  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 7, 2008-01 ,pp. : 857-869

Informa Healthcare

Access to resources Recommend Favorite

Therapie mit Entecavir bei chronischer Hepatitis B: BEHoLD-Studie (Benefits of Entecavir for Hepatitis B Liver Disease)

By Erhardt A.   Häussinger A.  

Der Internist, Vol. 48, Iss. 2, 2007-02 ,pp. : 208-210

Springer Publishing Company

Access to resources Recommend Favorite